BioAdaptives, Inc.
BDPT
$0.0653
-$0.0147-18.38%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.70K | 19.90K | 35.50K | 37.10K | 28.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.70K | 19.90K | 35.50K | 37.10K | 28.50K |
| Cost of Revenue | 90.00K | 94.50K | 45.50K | 24.70K | 17.70K |
| Gross Profit | -77.30K | -74.60K | -9.90K | 12.50K | 10.90K |
| SG&A Expenses | 504.80K | 242.80K | 240.10K | 242.80K | 211.60K |
| Depreciation & Amortization | 1.90K | -8.90K | 28.70K | 29.40K | 28.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 596.70K | 328.40K | 314.40K | 297.00K | 257.60K |
| Operating Income | -584.00K | -308.50K | -278.80K | -259.70K | -228.90K |
| Income Before Tax | -899.10K | -795.60K | -771.10K | -732.00K | -712.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.90 | -0.80 | -0.77 | -0.73 | -0.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -899.10K | -795.60K | -771.10K | -732.00K | -712.50K |
| EBIT | -584.00K | -308.50K | -278.80K | -259.70K | -228.90K |
| EBITDA | -582.10K | -299.50K | -232.20K | -212.50K | -182.90K |
| EPS Basic | -0.12 | -0.10 | -0.10 | -0.12 | -0.23 |
| Normalized Basic EPS | -0.07 | -0.07 | -0.05 | -0.06 | -0.13 |
| EPS Diluted | -0.12 | -0.10 | -0.10 | -0.12 | -0.23 |
| Normalized Diluted EPS | -0.07 | -0.07 | -0.05 | -0.06 | -0.13 |
| Average Basic Shares Outstanding | 28.39M | 32.71M | 31.60M | 28.58M | 23.83M |
| Average Diluted Shares Outstanding | 28.39M | 32.71M | 31.60M | 28.58M | 23.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |